MIRACLE - art photonics

Latest News

27 April 2026

Introducing the FlexiSpec Combi Fiber Optic Probes

By Stanislav Perevoschikov

In the demanding fields of bio-pharma and advanced R&D, real-time data is essential. Traditionally, securing comprehensive analytical data meant physically switching between different spectroscopic setups, such as ATR, NIR, and Raman. This fragmented approach not only slows down critical processes but also introduces a higher risk of sampling errors. Why run three separate analyses when […]

17 March 2026

Application Note: Identification of Organic and Pharmaceutical Powders

By Stanislav Perevoschikov

Real-time, in-line powder identification usually means a trade-off between speed and accuracy. We proved it doesn't have to. We recently teamed up with our Nynomic Group partner, m-u-t GmbH, to release a joint Application Note. The goal was simple: build a compact, field-ready NIR setup capable of analyzing complex organics directly in the bulk material, […]

Latest Events

4 May 2026

EuroPACT 2026 | 4-7 May 2026 | Lyon, France

By Stanislav Perevoschikov

The 7th European Conference on Process Analytics and Control Technology (EuroPACT 2026) is taking place from May 4th to 7th at the Cité - Centre de Congrès in Lyon, France. art photonics is pleased to announce that our CEO, Dr. Stefanie Foerster, will be attending the event to connect with industry leaders, partners, and innovators […]

28 April 2026

Day 1 at EPIC AGM 2026 | 28-30 April 2026 | Juan-les-Pins, Nice, France

By Stanislav Perevoschikov

Bonjour from Juan-les-Pins! Day 1 of the EPIC AGM & Summit 2026 is here, and art photonics GmbH is ready for an incredible event. Our CEO, Dr. Stefanie Foerster, has already engaged in some insightful discussions, kicking things off right alongside Carlos Lee, Director General of EPIC. We extend a warm thank you to the […]

MIRACLE: Mid-infrared arthroscopy innovative imaging system for real-time clinical in depth examination and diagnosis of degenerative joint diseases

MIRACLE will push towards commercialisation the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The proposed device is intended for use during arthroscopy, a minimally invasive surgery. Currently, the surgeon’s decision-making is based on visual inspection and manual probing of the cartilage tissue which is highly subjective and of poor repeatability. MIRACLE concept is to assess changes to the biochemical composition of articular cartilage, which precede OA. This will be achieved combining three novel photonics components: (i) a quantum cascade laser array tailored to biodiagnostics, (ii) an on-chip beam combiner for efficient radiation coupling, and (iii) a MIR sensing probe for imaging. These components will be integrated in a medical device to be placed in the arthroscopy market. In addition, to add value to the European medical equipment industry, MIRACLE strives towards cost reduction of OA patients contributing to more affordable public healthcare and promoting well-being in the European ageing population.

art photonics‘ role in joint work will be to develop and provide flexible IR-fibers for quantum cascade lasers (QCL) coupling with the distal end of arthroscopic probe.

The unique polycrystalline fiber technology for 4-16µm range and unique design of ATR-diamond tip will enable efficient and flexible coupling of QCL with detector. This worldwide first prototype of IR-fiber spectral sensor will open the first opportunity to see molecular changes in cartilage composition in-vivo, to link them with its specific decease and find the best way of the related treatment for a fast cartilage recovery.

This project received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 780598. The project is an initiative of the Photonics Public Private Partnership.